India to Zimbabwe: Dolutegravir Export Trade Route

The India to Zimbabwe Dolutegravir corridor is one of India's established pharmaceutical export routes, with 267 shipments documented worth a combined $31.6M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's dolutegravir manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $118.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with dolutegravir's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #14 among India's top dolutegravir export destinations globally.

On the import side, key buyers of Indian dolutegravir in Zimbabwe include MINISTRY OF HEALTH AND CHILD CARE, MINISTRY OF HEALTH AND CHILD CARE HARARE, XXiteXXNatXXns XXvelXXmenXXProXXammX and 18 others. MINISTRY OF HEALTH AND CHILD CARE is the single largest importer with 81 shipments valued at $13.4M USD.

India's dolutegravir exports to Zimbabwe are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 184 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Zimbabwe benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, EMCURE PHARMACEUTICALS LIMITED, LAURUS LABS LTD — together account for 89% of total trade value on this route. The average shipment value of $118.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as dolutegravir + lamivudine + tenofovir di and dolutegravir as sodium + lamivudine +, suggesting that buyers in Zimbabwe tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MINISTRY OF HEALTH AND CHILD CARE is the largest importer with 81 shipments worth $13.4M USD — representing 42% of all dolutegravir imports from India on this route. A total of 21 buyers are active on this corridor.